1Lee JY, Kim KM, Lee SG, et al. Prevalence and risk factors of non alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol, 2007, 47: 239-244.
2Tran TT, Changsri C, Shackleton CR, et al. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol, 2006, 21:381-383.
3Nadalin S, Malago M, Valentin-Gamazo C, et al. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl, 2005,11:980-986.
4Yamamoto K, Takada Y, Fujimoto Y, et al. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation, 2007, 83: 257-262.
5Park SH, Kim PN, Kim KW, et al. Maerovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology, 2006, 239: 105-112.
6Ryan CK, Johnson LA, Germin BI, et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl, 2002, 8:1114-1122.
7Urena MA, Ruiz-Delgado FC, Gonzalez EM, et al. Assessing risk of the use of livers with macro and mierosteatosis in a liver transplant program. Transplant Proc, 1998, 30: 3288-3291.
8Xu C, Yu C, Li Y. Current studies on therapeutic approaches for ischemia/reperfusion injury in steatotic livers. Hepatol Res, 2008, 38: 851-859.
9Nikeghbalian S. Nejatollahi SM. Salahi H. et al. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation. Transplant Proc, 2007, 39:1181-1183.
10KwonCH, JohJW, Lee NW, et al. Safety of donors with fatty liver in liver transplantation. Transplant Proc, 2006. 38: 21116- 2107.
